Pharmaceutical company Moderna — cofounded by a Cornell-educated medical pioneer — announced promising results in its development of a coronavirus vaccine on Nov. 16. With a vaccine efficacy rate of ...

Six years after early vaccine trials, the legacy of COVID-19 shots reflects science, public debate, and how perceptions ...

WASHINGTON (WCSC) - Sunday marks five years since Moderna’s COVID-19 vaccine was found to be 95.4% effective in its clinical trial. The company announced on Nov. 16, 2020, a major breakthrough in the ...

Nov 16 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the ...

Hughes is a partner with the law firm Epstein Becker Green and a professorial lecturer in law at the George Washington University Law School. He previously served as vice president of public policy at ...

FRANKFURT (Reuters) - Moderna and Pfizer-BioNTech are in a tight race to launch their COVID-19 vaccines in Europe after both applied for emergency EU approval on Tuesday, though there was uncertainty ...

Explore how Moderna makes money through its mRNA vaccines, government contracts, and partnerships, and how products like its COVID-19 vaccine drive revenue.